Company Profile
Benxi Herui Biomedical Technology Co., Ltd. was founded at the beginning of 2014, and it is situated in Benxi Pharmaceutical Industrial Park, which is a national biological pharmaceutical technological industrial base in Liaoning province. Herui is a service-type enterprise engaged in the R&D, production and sales of pharmaceutical and chemical intermediates. Herui adheres to the attitude of “honesty-oriented, factualism innovation, forge ahead with determination”. Based on its own effort and relevant supports offered by high and new tech development zone, the company has developed into a comprehensive laboratory with experienced R&D team and perfect supporting facilities. Members of our R&D team are graduates from Shenyang Pharmaceutical University, thus they has favorable theoretical basis and practical ability. In addition, the members has engaged in the R&D and production of pharmaceuticals for long term.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(R)-Lansoprazole |
1H-Benzimidazole,2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-,(R)-;2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;(+)-Lansoprazole;R-(+)-Lansoprazole;(R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;(R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;Dexlansoprazole;(R)-Lansoprazole;T 168390;TAK 390;Dexilant;Dextrolansoprazole;(+)-Lansoprazol;2-[(R)-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole;1336907-93-7 |
138530-94-6 | Inquiry | |
1H-Indole-3-butanoic acid |
1H-Indole-3-butanoic acid;Indole-3-butyric acid;IBA;γ-(Indol-3-yl)butyric acid;3-Indolylbutyric acid;3-Indolyl-γ-butyric acid;4-(Indol-3-yl)butyric acid;γ-(Indole-3)-butyric acid;Indolebutyric acid;1H-Indole-3-butyric acid;Indole-3-butanoic acid;Hormodin;Seradix;β-IBA;β-Indolebutyric acid;Seradix 2;Hormex;β-Indolylbutyric acid;Seradix B 3;Seradix B 2;Seradix 3;4-(3-Indolyl)butanoic acid;Oxyberon;[3-(3-Indolyl)propyl]carboxylic acid;Stim-Root;4-(1H-Indol-3-yl)butanoic acid;4-(1H-Indol-3-yl)butyric acid;NSC 3130;Clonex (rooting hormone);Clonex;Rootex;Kornevin;111150-79-9;65216-51-5 |
133-32-4 | Inquiry | |
3-Indoleacetonitrile |
1H-Indole-3-acetonitrile;Indole-3-acetonitrile;3-Indolylacetonitrile;Indoleacetonitrile;Indolylacetonitrile;3-(Cyanomethyl)indole;IAN;3-Cyanomethyl-1H-indole;NSC 523272;(1H-Indol-3-yl)acetonitrile;2-(1H-Indol-3-yl)acetonitrile |
771-51-7 | Inquiry | |
4,4'-Bis(2-bromoacetyl)biphenyl |
Ethanone,1,1′-[1,1′-biphenyl]-4,4′-diylbis[2-bromo-;4′,4′′′-Biacetophenone,2,2′′-dibromo-;1,1′-[1,1′-Biphenyl]-4,4′-diylbis[2-bromoethanone];p,p′-Bis(bromoacetyl)biphenyl;α,α′-Dibromo-4,4′-biacetophenone;4,4′-Bis(bromoacetyl)biphenyl;NSC 619613;4,4′-Bis(2-bromoacetyl)biphenyl;1,1′-[1,1′-Biphenyl]-4,4′-diylbis[2-bromoethan-1-one];2-Bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone |
4072-67-7 | Inquiry | |
4,4'-Diacetylbiphenyl |
BIS-ACETOPHENONE;4'-Diacetylbiphenyl;4,4'-DIACETYLBIPHENYL;4',4''-BIACETOPHENONE;p,p'-Diacetyldiphenyl;4,4'-Diacetylbiphenyl 98%;4,4'-Diacetylbiphenyl,98%;4,4'-Diacetylbiphenyl ,99%;4,4'-Diacetyl-1,1'-biphenyl;Daclatasvir Intermediates 1 |
787-69-9 | Inquiry | |
5-Bromoindole |
1H-Indole,5-bromo-;Indole,5-bromo-;5-Bromo-1H-indole;5-Bromoindole;NSC 75581 |
10075-50-0 | Inquiry | |
5-Nitroindole |
1H-Indole,5-nitro-;Indole,5-nitro-;5-Nitro-1H-indole;5-Nitroindole;NSC 520594 |
6146-52-7 | Inquiry | |
6-Methoxyindole |
1H-Indole,6-methoxy-;Indole,6-methoxy-;6-Methoxy-1H-indole;6-Methoxyindole;NSC 92517;6-(Methyloxy)-1H-indole |
3189-13-7 | Inquiry | |
Apixaban |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide;BMS 562247-01;Apixaban;Eliquis;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-47-3 | Inquiry | |
Ezetimibe |
2-Azetidinone,1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-,(3R,4S)-;2-Azetidinone,1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-,[3R-[3α(S*),4β]]-;(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone;Sch 58235;Ezetimibe;(-)-Sch 58235;Zetia;Ezetrol;Ezta;Ezedoc;1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one;Ezentia |
163222-33-1 | Inquiry | |
Fmoc-AEEA |
3,6,11-Trioxa-9-azadodecanoic acid,12-(9H-fluoren-9-yl)-10-oxo-;2,7,10-Trioxa-4-azadodecan-12-oic acid,1-(9H-fluoren-9-yl)-3-oxo-;12-(9H-Fluoren-9-yl)-10-oxo-3,6,11-trioxa-9-azadodecanoic acid;8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic acid;9-Fluorenylmethoxycarbonyl-8-amino-3,6-dioxaoctanoic acid;8-(Fmoc-amino)-3,6-dioxaoctanoic acid;[2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid;Fmoc-NH-PEG2-CH2COOH;1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid;Fmoc-aeea;2-[2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid;2-[2-[2-([[(9H-Fluoren-9-yl)methoxy]carbonyl]amino)ethoxy]ethoxy]acetic acid;1776111-66-0;2096497-78-6 |
166108-71-0 | Inquiry | |
Isradipine |
3,5-Pyridinedicarboxylic acid,4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-,3-methyl 5-(1-methylethyl) ester;3,5-Pyridinedicarboxylic acid,4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-,methyl 1-methylethyl ester;3,5-Pyridinedicarboxylic acid,4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-,methyl 1-methylethyl ester;2,1,3-Benzoxadiazole,3,5-pyridinedicarboxylic acid deriv.;Isradipin;Isradipine;PN 200-110;Lomir;PN 200;(±)-Isradipine;DynaCire;DynaCire CR;Esradin;Clivoten;Prescal;Rebriden;Isrodipine;DynaCirc;Dynacrine;3-O-Methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;88977-22-4 |
75695-93-1 | Inquiry | |
Lansoprazole |
1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;AG 1749;Lansoprazole;A 65006;(±)-Lansoprazole;Prevacid;PP/K-10;Lanfast;Lanzor;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;Ilsatec;Agopton;Lanproton;Lansopep;Lanston;Lanz;Lanzol 30;Lanzopral;Ogastro;Promp;Prosogan;Suprecid;Takepron;Ulpax;Zoton;Ketian;Lancid;Ogast;Lansophed;Lapraz;Lansox;Takepron OD;Tapepron;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole;Lansor;Lanzol;Lansofast;Propilan;Lanzole;Lanzopen;2-[[[4-(2,2,2-Trifluoroethoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole;Lanpro;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole;Lanzo;Cinfa;Davur;Alter;Lanso;(±)-Lansoprazol;Levant;RS-lansoprazole;Lasoprazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole;154727-72-7;909251-59-8 |
103577-45-3 | Inquiry | |
N-tert-Butoxycarbonyl-L-dopa |
Boc-3,4-dihydroxy-L-phenylalanine;Boc-L-phe(3,4-OH2)-OH;N-Boc-3,4-dihydroxy-L-phenylalanine;Boc-DOPA;Boc-L-DOPA;N-Boc-DOPA;N-Boc-(L)-Dopa;N-(tert-butoxycarbonyl) DOPA;SCHEMBL1172086;Boc-D-phe(3,4-OH2)-OH |
30033-24-0 | Inquiry | |
Prasugrel hydrochloride |
Ethanone,2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-,hydrochloride (1:1);Ethanone,2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-,hydrochloride;Prasugrel hydrochloride;2-Acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride;Prasu Doc;Efient;Effient |
389574-19-0 | Inquiry | |
Sitagliptin phosphate Monohydrate |
1-Butanone,3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-,(3R)-,phosphate,hydrate (1:1:1);1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-,phosphate (1:1),monohydrate;(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogen phosphate monohydrate;Sitagliptin phosphate monohydrate;1253056-03-9 |
654671-77-9 | Inquiry |
CONTACT INFORMATION
Sign In for Details